Sei Morinaga

697 total citations
90 papers, 408 citations indexed

About

Sei Morinaga is a scholar working on Pulmonary and Respiratory Medicine, Biotechnology and Oncology. According to data from OpenAlex, Sei Morinaga has authored 90 papers receiving a total of 408 indexed citations (citations by other indexed papers that have themselves been cited), including 39 papers in Pulmonary and Respiratory Medicine, 39 papers in Biotechnology and 35 papers in Oncology. Recurrent topics in Sei Morinaga's work include Cancer Research and Treatments (39 papers), Sarcoma Diagnosis and Treatment (34 papers) and Virus-based gene therapy research (20 papers). Sei Morinaga is often cited by papers focused on Cancer Research and Treatments (39 papers), Sarcoma Diagnosis and Treatment (34 papers) and Virus-based gene therapy research (20 papers). Sei Morinaga collaborates with scholars based in Japan, United States and Philippines. Sei Morinaga's co-authors include Kentaro Igarashi, Katsuhiro Hayashi, Shinji Miwa, Hiroyuki Tsuchiya, Akihiko Takeuchi, Norio Yamamoto, Qinghong Han, Robert M. Hoffman, Yoshihiro Araki and Hirotaka Yonezawa and has published in prestigious journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and Scientific Reports.

In The Last Decade

Sei Morinaga

70 papers receiving 407 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Sei Morinaga Japan 11 178 171 140 103 91 90 408
S. Smith United States 3 161 0.9× 345 2.0× 77 0.6× 31 0.3× 23 0.3× 5 506
Dan Draganovici Germany 8 36 0.2× 98 0.6× 17 0.1× 44 0.4× 50 0.5× 8 417
Adam G. Baseman United States 7 149 0.8× 129 0.8× 21 0.1× 22 0.2× 61 0.7× 8 423
Ibrahim M. Sektioglu Germany 4 56 0.3× 305 1.8× 13 0.1× 26 0.3× 76 0.8× 4 587
Gordana Đorđević Croatia 12 116 0.7× 115 0.7× 22 0.2× 23 0.2× 86 0.9× 33 385
Guochuan Zhang China 9 153 0.9× 140 0.8× 7 0.1× 28 0.3× 137 1.5× 20 354
Himanshu M Doshi United States 6 127 0.7× 248 1.5× 60 0.4× 20 0.2× 9 0.1× 7 381
Se Kyu Kim South Korea 8 194 1.1× 213 1.2× 11 0.1× 17 0.2× 99 1.1× 11 391
Motohisa Takami Japan 8 113 0.6× 139 0.8× 16 0.1× 15 0.1× 23 0.3× 17 413
M. Rosa Sollazzo Italy 10 239 1.3× 159 0.9× 12 0.1× 35 0.3× 74 0.8× 11 429

Countries citing papers authored by Sei Morinaga

Since Specialization
Citations

This map shows the geographic impact of Sei Morinaga's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Sei Morinaga with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Sei Morinaga more than expected).

Fields of papers citing papers by Sei Morinaga

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Sei Morinaga. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Sei Morinaga. The network helps show where Sei Morinaga may publish in the future.

Co-authorship network of co-authors of Sei Morinaga

This figure shows the co-authorship network connecting the top 25 collaborators of Sei Morinaga. A scholar is included among the top collaborators of Sei Morinaga based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Sei Morinaga. Sei Morinaga is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Morinaga, Sei, Byung Mo Kang, Norio Yamamoto, et al.. (2025). Prostate Cancer Patient With Lymph-node Metastasis Treated Only With Methionine Restriction Has Stable Disease for Two Years Demonstrated With PET/CT and PSMA-PET Scanning and PSA Testing. Cancer Diagnosis & Prognosis. 5(1). 27–31. 1 indexed citations
3.
Kubota, Yutaro, Ming Zhao, Qinghong Han, et al.. (2025). Engineered Methioninase-expressing Tumor-targetingSalmonella typhimuriumA1-R Inhibits Syngeneic-Cancer Mouse Models by Depleting Tumor Methionine. Cancer Genomics & Proteomics. 22(2). 247–257. 1 indexed citations
4.
Kubota, Yutaro, et al.. (2024). Selective Synergy of Rapamycin Combined With Methioninase on Cancer Cells Compared to Normal Cells. Anticancer Research. 44(3). 929–933. 9 indexed citations
5.
Morinaga, Sei, Byung Mo Kang, Michael Bouvet, et al.. (2024). The Combination of Methionine Restriction and Docetaxel Synergistically Arrests Androgen-independent Prostate Cancer But Not Normal Cells. Cancer Diagnosis & Prognosis. 4(4). 402–407. 1 indexed citations
7.
Asano, Yohei, Norio Yamamoto, Satoru Demura, et al.. (2023). Novel predictors of immune checkpoint inhibitor response and prognosis in advanced non‐small‐cell lung cancer with bone metastasis. Cancer Medicine. 12(11). 12425–12437. 13 indexed citations
8.
Miwa, Shinji, Norio Yamamoto, Katsuhiro Hayashi, et al.. (2023). Graft Survivals after Reconstruction Using Tumor-Bearing Frozen Bone in the Extremities. Cancers. 15(15). 3926–3926. 2 indexed citations
11.
Araki, Yoshihiro, Norio Yamamoto, Katsuhiro Hayashi, et al.. (2022). A Viability Analysis of Tumor-Bearing Frozen Autograft for the Reconstruction After Resection of Malignant Bone Tumors Using 99mTc-MDP Scintigraphy. Clinical Nuclear Medicine. 48(1). 25–34. 1 indexed citations
12.
Araki, Yoshihiro, Norio Yamamoto, Katsuhiro Hayashi, et al.. (2022). Primary Osteosarcoma in Patients Over 75 Years of Age: A Case Series and Literature Review. In Vivo. 36(6). 2899–2909. 4 indexed citations
13.
Yamamoto, Norio, Katsuhiro Hayashi, Akihiko Takeuchi, et al.. (2022). Clinical Outcomes of Soft Tissue Sarcoma around the Elbow Joint: A Retrospective Single Institution Study. Sarcoma. 2022. 1–8. 1 indexed citations
14.
Araki, Yoshihiro, Norio Yamamoto, Katsuhiro Hayashi, et al.. (2021). The number of osteoclasts in a biopsy specimen can predict the efficacy of neoadjuvant chemotherapy for primary osteosarcoma. Scientific Reports. 11(1). 1989–1989. 10 indexed citations
15.
Araki, Yoshihiro, Norio Yamamoto, Katsuhiro Hayashi, et al.. (2021). Author Correction: The number of osteoclasts in a biopsy specimen can predict the efficacy of neoadjuvant chemotherapy for primary osteosarcoma. Scientific Reports. 11(1). 8831–8831. 1 indexed citations
17.
Araki, Yoshihiro, Norio Yamamoto, Katsuhiro Hayashi, et al.. (2021). Clinical outcomes of frozen autograft reconstruction for the treatment of primary bone sarcoma in adolescents and young adults. Scientific Reports. 11(1). 17291–17291. 12 indexed citations
18.
Miwa, Shinji, Norio Yamamoto, Katsuhiro Hayashi, et al.. (2021). A Radiological Scoring System for Differentiation between Enchondroma and Chondrosarcoma. Cancers. 13(14). 3558–3558. 9 indexed citations
19.
Hayashi, Katsuhiro, Norio Yamamoto, Akihiko Takeuchi, et al.. (2020). Clinical course of grafted cartilage in osteoarticular frozen autografts for reconstruction after resection of malignant bone and soft-tissue tumor involving an epiphysis. Journal of bone oncology. 24. 100310–100310. 10 indexed citations
20.
Araki, Yoshihiro, Norio Yamamoto, Katsuhiro Hayashi, et al.. (2020). Secondary Osteoarthritis After Curettage and Calcium Phosphate Cementing for Giant-Cell Tumor of Bone Around the Knee Joint. JBJS Open Access. 5(3). e19.00068–e19.00068. 8 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026